1. Malaria Vaccines: Progress to Date

   • Danielle I. Stanisic
   • Michael F. Good

   Review Article Open access 20 September 2023 Pages: 737 - 756

2. Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies

   • Parul Berry
   • Sahil Khanna

   Review Article 26 July 2023 Pages: 757 - 773

   

3. Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer

   • Khaled Sanber
   • Samuel Rosner
   • Kristen A. Marrone

   Review Article 21 August 2023 Pages: 775 - 791

   

4. Enzyme Engineering Strategies for the Bioenhancement of l-Asparaginase Used as a Biopharmaceutical

   • Javiera Miranda
   • Nicolás Lefin
   • Mauricio Zamorano

   Review Article 12 September 2023 Pages: 793 - 811

   

5. Treatment with Biologic Drugs in Pediatric Behçet’s Disease: A Comprehensive Analysis of the Published Data

   • Ezgi Deniz Batu
   • Seher Sener
   • Seza Ozen

   Review Article 29 June 2023 Pages: 813 - 828

   

6. Patients’ Perceptions of Biosimilars: A Systematic Review

   • Qiyou Wu
   • Zhitao Wang
   • Jing Sun

   Systematic Review 07 September 2023 Pages: 829 - 841

   

7. Acute Kidney Injury from Intravitreal Anti-vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-analysis of Randomized Controlled Trials

   • Yu-Chien Tsao
   • Ting-Ying Chen
   • Edward Chia-Cheng Lai

   Systematic Review 07 September 2023 Pages: 843 - 854

   

8. Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars?

   • Nadine Kirsch-Stefan
   • Elena Guillen
   • Elena Wolff-Holz

   Original Research Article Open access 13 October 2023 Pages: 855 - 871

   

9. The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune‐Mediated Inflammatory Disease

   • Ulf Müller-Ladner
   • Axel Dignass
   • Janet Addison

   Original Research Article Open access 26 August 2023 Pages: 873 - 889

   

10. Real-World Clinical Outcomes of Bevacizumab-awwb Biosimilar versus Bevacizumab Reference Product in Patients with Metastatic Colorectal Cancer

    • Catherine Pham
    • Fang Niu
    • Rita L. Hui

    Original Research Article 25 September 2023 Pages: 891 - 899